REGN | Regeneron Pharmaceuticals
Category: Biotechnology company
Quick infos Headquarters: Tarrytown, New York, United States Trade prices Volume: 376K Market Cap: 65.4B Prev closed: 609.17 Open: 612.1 High: 630.76 Low: 608.76 52 week low: 271.37 52 week high: 646.33 Dividends: No Dividends Next ER: February 3, 2023 Before Market Opens
About the Company Regeneron Pharmaceuticals, Inc. is a biotechnology company headquartered in Tarrytown, New York. The company was founded in 1988.
Earnings History Date EPS / Forecast Revenue / Forecast May 4, 2023 February 3, 2023 12.56 / 10.173.41B / 3.13BBeat! November 3, 2022 11.14 / 9.822.94B / 2.94BAugust 3, 2022 9.77 / 8.622.86B / 2.79BBeat! May 4, 2022 11.49 / 9.722.97B / 2.69BBeat! view more
Historical Data Date Price Open High Low Vol Change ER Aug 16, 2022 648.70 643.49 649.77
639.70
602.89K 0.84% Aug 15, 2022 643.29 628.70 643.60
624.80
539.21K 2.32% Aug 12, 2022 628.71 628.87 632.57
622.30
351.28K 0.77% Aug 11, 2022 623.90 638.63 643.98
622.37
468.06K -2.74% Aug 10, 2022 641.49 630.00 645.95
624.78
681.69K 3.11% Aug 9, 2022 622.15 630.00 634.85
617.10
469.54K -1.34% Aug 8, 2022 630.63 619.78 633.93
618.87
715.23K 2.77% Aug 5, 2022 613.61 613.47 621.63
606.96
566.77K -0.22% Aug 4, 2022 614.96 602.65 623.35
602.65
695.07K 1.02% Aug 3, 2022 608.77 600.00 623.48
595.16
1.15M 5.88% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company ISIN: US75886F1075 CUSIP: 75886F107 Founded:1988 Employees:5,400 News
UNITY Biotechnology's Wet AMD Candidate Flunks On Non-Inferiority Threshold Compared To Regeneron's Drug finance.yahoo.com Mar 29, 2023 1:28 pm UPDATE 3-U.S. Supreme Court mulls Amgen bid to revive cholesterol drug patents finance.yahoo.com Mar 29, 2023 10:35 am
Regeneron and Sonoma Biotherapeutics Announce Collaboration to Discover, Develop and Commercialize Treg Cell Therapies for Autoimmune Diseases finance.yahoo.com Mar 29, 2023 7:30 am
Technical Assessment: Bearish in the Intermediate-Term finance.yahoo.com Mar 29, 2023 7:00 am
Students Win More Than $1.8 Million at 2023 Regeneron Science Talent Search for Remarkable Scientific Research on RNA Molecule Structure, Media Bias, and Diagnostics for Pediatric Heart Disease finance.yahoo.com Mar 28, 2023 9:30 pm
Drug, Chip Stocks Hit 52-Week Highs As One Breaks Out Of Bullish Chart Pattern finance.yahoo.com Mar 28, 2023 4:20 pm
Regeneron Breaks Out On Home Run In 'Smoker's Lung' As Sanofi Soars finance.yahoo.com Mar 28, 2023 4:02 pm
Unity (UNX) Down on Disappointing Results From Wet AMD Study finance.yahoo.com Mar 28, 2023 3:25 pm
The 7 Best Biotech Stocks to Buy for February 2023 finance.yahoo.com Mar 28, 2023 1:51 pm
Compared to Estimates, Regeneron (REGN) Q4 Earnings: A Look at Key Metrics finance.yahoo.com Mar 28, 2023 12:45 pm
Regeneron poised to benefit from bounce-back of eye drug finance.yahoo.com Mar 28, 2023 12:20 pm
Wall Street Has High Hopes for These 2 Nasdaq Stocks finance.yahoo.com Mar 28, 2023 12:02 pm
Biotech Stock Roundup: AMGN, GILD, BMY, REGN's Q4 Results, KPRX Up on Study Update finance.yahoo.com Mar 28, 2023 12:00 pm
Merck's drug boosts exercise capacity in pulmonary hypertension patients finance.yahoo.com Mar 28, 2023 12:00 pm
Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover finance.yahoo.com Mar 28, 2023 11:15 am
Medicare Negotiation Undercuts Biotech Stocks Regeneron, Halozyme finance.yahoo.com Mar 28, 2023 10:50 am
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q4 2022 Earnings Call Transcript (Corrected) finance.yahoo.com Mar 28, 2023 9:47 am
Analyst Report: Regeneron Pharmaceuticals, Inc. finance.yahoo.com Mar 28, 2023 9:21 am
Why Regeneron Pharmaceuticals And Sanofi Shares Are Trading Higher Today finance.yahoo.com Mar 28, 2023 9:20 am
Pharma Stock Roundup: SNY's COPD Study Meets Goal, ABBV Parkinson's Drug Gets CRL finance.yahoo.com Mar 28, 2023 9:04 am This company doesn't provide a dividend.
Key Persons CEO : Leonard S. Schleifer, MD, PhD Talk about Regeneron Pharmaceuticals below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon While many books explain the how of bitcoin, The Internet of Money delves into the why of bitcoin. Acclaimed information-security expert and author of Mastering Bitcoin, Andreas M. Antonopoulos examines and contextualizes the significance of bitcoin through a series of essays spanning the exhilarating maturation of this technology.
